Equities researchers at DA Davidson raised their FY2026 earnings per share (EPS) estimates for Amplitude in a report issued on Tuesday, March 11th. DA Davidson analyst C. Wright now forecasts that the ...

Meeting to be held in Boston on March 13 hosted by KeyBanc.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

RBC Capital analyst Gordon Ramsay upgraded Amplitude Energy (COPJF) to Outperform from Sector Perform with a price target of A$0.28, up from ...

Investment analysts at William Blair increased their Q2 2025 earnings per share estimates for Amplitude in a research note issued on Tuesday, March 11th. William Blair analyst A. Bhatia now ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

SAN FRANCISCO, March 07, 2025--(BUSINESS WIRE)--Amplitude (Nasdaq: AMPL), the leading digital analytics platform, will host its previously announced investor day on Monday, March 10, 2025 beginning at ...

PAI Partners has entered exclusive talks to sell majority stake in Amplitude Surgical, a European medical technology business, alongside the company’s management team and two minority shareholders.

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

Amplitude's enterprise sales strategy is driving significant ARR growth. See why I reiterate my buy rating on AMPL stock.